KROS vs MSFT: Which Stock is Better?
Side-by-side comparison of Keros Therapeutics Inc and Microsoft Corp in 2026
KROS
Keros Therapeutics Inc
$11.71
MSFT
Microsoft Corp
$415.05
Key Metrics Comparison
| Metric | KROS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $351.88M | N/A | KROS |
| P/E Ratio | 5.02 | 24.57 | KROS |
| EPS (TTM) | $2.30 | $16.00 | MSFT |
| Revenue Growth | -0.9% | 0.2% | MSFT |
| Gross Margin | 47.9% | 68.6% | MSFT |
Analyze KROS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KROS or MSFT a better investment?
Comparing KROS and MSFT: Keros Therapeutics Inc has a market cap of $351.88M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KROS and MSFT?
KROS (Keros Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KROS or MSFT?
Based on P/E ratios, KROS trades at a lower multiple (5.0x vs 24.6x).
Which is growing faster: KROS or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.9% for KROS.
Which company is more profitable: KROS or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 47.9% for KROS.
Which is the larger company: KROS or MSFT?
Keros Therapeutics Inc (KROS) is larger with a market cap of $351.88M compared to N/A for MSFT.
Should I buy KROS or MSFT in 2026?
Both KROS and MSFT have investment merit. KROS trades at $11.71 while MSFT trades at $415.05. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KROS and MSFT stock?
Key differences: Market Cap ($351.88M vs N/A), P/E Ratio (5.0x vs 24.6x), Revenue Growth (-0.9% vs 0.2%), Gross Margin (47.9% vs 68.6%).